Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Journal: The New England journal of medicine
Published: December 06, 2023
Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor-α positive ovarian cancer: The antibody-drug conjugate, payload and metabolite.
Journal: British journal of clinical pharmacology
Published: February 01, 2023
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 18, 2020
Antibody-Drug Conjugates for Cancer Treatment.
Journal: Annual review of medicine
Published: February 08, 2018
Showing 1-5 of 5
Last Updated: 09/26/2026